Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical BCR-ABL1 Transcripts

BCR-ABL1 fusion transcript is the minimal residual disease marker in chronic myeloid leukemia; 2% of patients show unusual breakpoints generating atypical transcripts, not quantifiable by standardized real-time PCR (RT–PCR). Response monitoring is performed by non-quantitative NESTED PCR, useless fo...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Med
Prif Awduron: Petiti, Jessica, Lo Iacono, Marco, Dragani, Matteo, Pironi, Lucrezia, Fantino, Cristina, Rapanotti, Maria Cristina, Quarantelli, Fabrizio, Izzo, Barbara, Divona, Mariadomenica, Rege-Cambrin, Giovanna, Saglio, Giuseppe, Gottardi, Enrico Marco, Cilloni, Daniela, Fava, Carmen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7290999/
https://ncbi.nlm.nih.gov/pubmed/32414125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9051457
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg